
Monica E. Millner
Examiner (ID: 13456, Phone: (571)270-7507 , Office: P/3632 )
| Most Active Art Unit | 3632 |
| Art Unit(s) | 3632, 3627, 3508 |
| Total Applications | 1500 |
| Issued Applications | 1152 |
| Pending Applications | 94 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5922971
[patent_doc_number] => 20020115607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Protein-protein interactions in neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 09/975072
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26414
[patent_no_of_claims] => 136
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115607.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975072
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975072 | Protein-protein interactions in neurodegenerative diseases | Oct 11, 2001 | Abandoned |
Array
(
[id] => 6082309
[patent_doc_number] => 20020082215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Method for treating ischemic events affecting the central nervous system'
[patent_app_type] => new
[patent_app_number] => 09/976620
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15644
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082215.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976620
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976620 | Method for treating ischemic events affecting the central nervous system | Oct 11, 2001 | Abandoned |
Array
(
[id] => 5921099
[patent_doc_number] => 20020114799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Protein-protein interactions in neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 09/973077
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26412
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20020114799.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973077 | Protein-protein interactions in neurodegenerative diseases | Oct 9, 2001 | Abandoned |
Array
(
[id] => 6761342
[patent_doc_number] => 20030124704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Nogo receptor homologs'
[patent_app_type] => new
[patent_app_number] => 09/972546
[patent_app_country] => US
[patent_app_date] => 2001-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 52016
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124704.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972546
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972546 | Nogo receptor homologs | Oct 5, 2001 | Abandoned |
Array
(
[id] => 1311886
[patent_doc_number] => 06610538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Reconstructed laminae of human epithelium corneae and method of producing the same'
[patent_app_type] => B2
[patent_app_number] => 09/961314
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3554
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610538.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961314
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961314 | Reconstructed laminae of human epithelium corneae and method of producing the same | Sep 24, 2001 | Issued |
Array
(
[id] => 7964271
[patent_doc_number] => 06680292
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-20
[patent_title] => 'Pharmaceutical composition comprising ribavirin and growth factors and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/856100
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 10879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856100
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856100 | Pharmaceutical composition comprising ribavirin and growth factors and methods of use | Sep 23, 2001 | Issued |
| 09/890579 | Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same | Sep 18, 2001 | Abandoned |
Array
(
[id] => 1080407
[patent_doc_number] => 06835565
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Alzheimer\'s disease secretase'
[patent_app_type] => B1
[patent_app_number] => 09/806194
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 12
[patent_no_of_words] => 38637
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835565.pdf
[firstpage_image] =>[orig_patent_app_number] => 09806194
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/806194 | Alzheimer's disease secretase | Sep 16, 2001 | Issued |
Array
(
[id] => 5788281
[patent_doc_number] => 20020160933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Methods and compositions for producing a neurosalutary effect in a subject'
[patent_app_type] => new
[patent_app_number] => 09/949200
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14975
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160933.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949200 | Methods and compositions for producing a neurosalutary effect in a subject | Sep 6, 2001 | Abandoned |
Array
(
[id] => 6778169
[patent_doc_number] => 20030049250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Method for enhancing endothelial function in humans'
[patent_app_type] => new
[patent_app_number] => 09/946174
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7778
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049250.pdf
[firstpage_image] =>[orig_patent_app_number] => 09946174
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/946174 | Method for enhancing endothelial function in humans | Sep 4, 2001 | Abandoned |
Array
(
[id] => 6567354
[patent_doc_number] => 20020165144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Human schizophrenia gene'
[patent_app_type] => new
[patent_app_number] => 09/946807
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27004
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09946807
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/946807 | Human schizophrenia gene | Sep 4, 2001 | Abandoned |
Array
(
[id] => 1245520
[patent_doc_number] => 06677124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Monoclonal antibody recognizing C-terminus of hBNP'
[patent_app_type] => B2
[patent_app_number] => 09/942709
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5755
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677124.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942709
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942709 | Monoclonal antibody recognizing C-terminus of hBNP | Aug 30, 2001 | Issued |
Array
(
[id] => 1248072
[patent_doc_number] => 06673603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Cell paste comprising keratinocytes and fibroblasts'
[patent_app_type] => B2
[patent_app_number] => 09/943114
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8833
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673603.pdf
[firstpage_image] =>[orig_patent_app_number] => 09943114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/943114 | Cell paste comprising keratinocytes and fibroblasts | Aug 29, 2001 | Issued |
Array
(
[id] => 1005223
[patent_doc_number] => 06905815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-14
[patent_title] => 'Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1'
[patent_app_type] => utility
[patent_app_number] => 10/111373
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5122
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/905/06905815.pdf
[firstpage_image] =>[orig_patent_app_number] => 10111373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/111373 | Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1 | Aug 23, 2001 | Issued |
Array
(
[id] => 1095640
[patent_doc_number] => 06821743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-23
[patent_title] => 'Human endothelin receptor'
[patent_app_type] => B2
[patent_app_number] => 09/931157
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7756
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931157
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931157 | Human endothelin receptor | Aug 15, 2001 | Issued |
Array
(
[id] => 6838771
[patent_doc_number] => 20030036111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Mitochondrial protein'
[patent_app_type] => new
[patent_app_number] => 09/923921
[patent_app_country] => US
[patent_app_date] => 2001-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13298
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036111.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923921 | Mitochondrial protein | Aug 6, 2001 | Abandoned |
Array
(
[id] => 1208904
[patent_doc_number] => 06713246
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Method of producing interleukin-1 receptor antagonist in a syringe filled with blood'
[patent_app_type] => B1
[patent_app_number] => 09/890723
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7340
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713246.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890723 | Method of producing interleukin-1 receptor antagonist in a syringe filled with blood | Jul 31, 2001 | Issued |
| 09/674292 | Induction of neuronal regeneration | Jul 31, 2001 | Abandoned |
Array
(
[id] => 1253178
[patent_doc_number] => 06670179
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth'
[patent_app_type] => B1
[patent_app_number] => 09/920213
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2766
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670179.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920213 | Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth | Jul 31, 2001 | Issued |
Array
(
[id] => 5873792
[patent_doc_number] => 20020048746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Model for alzheimer\'s disease and other neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 09/917789
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 37262
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048746.pdf
[firstpage_image] =>[orig_patent_app_number] => 09917789
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/917789 | Model for Alzheimer's disease and other neurodegenerative diseases | Jul 30, 2001 | Issued |